Unknown

Dataset Information

0

IGF-dependent dynamic modulation of a protease cleavage site in the intrinsically disordered linker domain of human IGFBP2.


ABSTRACT: Functional regulation via conformational dynamics is well known in structured proteins but less well characterized in intrinsically disordered proteins and their complexes. Using NMR spectroscopy, we have identified a dynamic regulatory mechanism in the human insulin-like growth factor (IGF) system involving the central, intrinsically disordered linker domain of human IGF-binding protein-2 (hIGFBP2). The bioavailability of IGFs is regulated by the proteolysis of IGF-binding proteins. In the case of hIGFBP2, the linker domain (L-hIGFBP2) retains its intrinsic disorder upon binding IGF-1, but its dynamics are significantly altered, both in the IGF binding region and distantly located protease cleavage sites. The increase in flexibility of the linker domain upon IGF-1 binding may explain the IGF-dependent modulation of proteolysis of IGFBP2 in this domain. As IGF homeostasis is important for cell growth and function, and its dysregulation is a key contributor to several cancers, our findings open up new avenues for the design of IGFBP analogs inhibiting IGF-dependent tumors.

SUBMITTER: Jaipuria G 

PROVIDER: S-EPMC9357107 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

IGF-dependent dynamic modulation of a protease cleavage site in the intrinsically disordered linker domain of human IGFBP2.

Jaipuria Garima G   Shet Divya D   Malik Shahid S   Swain Monalisa M   Atreya Hanudatta S HS   Galea Charles A CA   Slomiany Mark G MG   Rosenzweig Steven A SA   Forbes Briony E BE   Norton Raymond S RS   Mondal Somnath S  

Proteins 20220430 9


Functional regulation via conformational dynamics is well known in structured proteins but less well characterized in intrinsically disordered proteins and their complexes. Using NMR spectroscopy, we have identified a dynamic regulatory mechanism in the human insulin-like growth factor (IGF) system involving the central, intrinsically disordered linker domain of human IGF-binding protein-2 (hIGFBP2). The bioavailability of IGFs is regulated by the proteolysis of IGF-binding proteins. In the case  ...[more]

Similar Datasets

| S-EPMC7277182 | biostudies-literature
| S-EPMC5761276 | biostudies-literature
| S-EPMC5343758 | biostudies-literature
| S-EPMC9106000 | biostudies-literature
| S-EPMC4339304 | biostudies-literature
| S-EPMC6881172 | biostudies-literature
| S-EPMC4807257 | biostudies-literature
| S-EPMC3725778 | biostudies-literature
| S-EPMC2747730 | biostudies-literature
| S-EPMC4532373 | biostudies-literature